One Platform. Complete Business Development Intelligence.
How Beacon Helps Business Development Teams:
- Identify potential licensing, partnering and acquisition opportunities across programmes, companies, targets, modalities and disease areas.
- Evaluate scientific and clinical differentiation by benchmarking assets against competing approaches, development paths and emerging evidence.
- Prioritise opportunities faster with connected pipeline, company, trial and deal intelligence in one searchable source of truth.
- Build stronger, evidence-backed investment cases that align promising external innovation with portfolio strategy and unmet need.
Why Leading Business Development Teams Choose Beacon
Beacon goes beyond generic databases and AI tools, connecting scientific, clinical, company and deal intelligence so business development teams can find, qualify and defend opportunities with confidence.
Modality & Disease-Specific Datasets
Analyze the full competitive landscape. Includes the 20-30% of data AI engines miss.
Subject Matter Expert-Led Curation
Curated by scientists, trusted by strategists to deliver decision-grade intelligence
Holistic Preclinical & Clinical Data
From discovery to clinic, depth and context no generic platform can match.
Granular Ontologies & Modality-Specific Data
From “who is active” to “what wins” benchmark what drives differentiation.
Structured, AI-ready Data
Power your analytics and automation workflows. Gold-standard data in, gold-standard decisions out.
Why Generic Databases and AI Engines Fall Short
The difference is clear. Beacon delivers decision-grade intelligence designed specifically for drug development.
| What Matters | Generic Databases | AI Engines | Beacon |
| Landscape Completeness | Broad, but shallow | Highly variable; significant omissions | Access the full landscape, including the 20-30% others miss |
| Preclinical depth | Limited or absent | Largely missing from model outputs | Core strength, curated from grey literature upwards |
| Scientific granularity | Company, indication, phase of development | Unstructured narrative text | 90+ modality-specific filters and ontologies |
| Curation | Largely automated aggregation | None, model inference only | Curated by sector scientists, zero tolerance for errors |
| Consistency | Varies with refresh cycles and versioning | Answers vary between identical queries | Deterministic, the same query returns the same result |
| Defensibility | Partial sourcing; re-validation needed | Sources often missing, paraphrased or fabricated | 100% traceable, board and portfolio ready |
Accelerate Partnering Decisions with Decision-Grade Intelligence
Find differentiated opportunities, evaluate strategic fit and build stronger business cases with confidence.
Search